Portal hypertension and iron depletion in patients with genetic hemochromatosis

Clinically, portal hypertension has been considered to be less common and less severe in patients with cirrhosis resulting from iron overload in homozygotes for genetic hemochromatosis than in patients with cirrhosis of other causes. To characterize the prevalence and progression of portal hypertens...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology (Baltimore, Md.) Md.), 1995-10, Vol.22 (4), p.1127-1131
Main Authors: Fracanzani, Anna Ludovica, Fargion, Silvia, Romano, Riccardo, Conte, Dario, Piperno, Alberto, D'Alba, Roberta, Mandelli, Clara, Fraquelli, Mirella, Pacchetti, Stefania, Braga, Mario, Fiorelli, Gemino
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Female
Gastroenterology. Liver. Pancreas. Abdomen
Hemochromatosis - complications
Hemochromatosis - genetics
Hemochromatosis - pathology
Hepatitis B - complications
Hepatitis C - complications
Humans
Hypertension, Portal - complications
Hypertension, Portal - pathology
Iron - deficiency
Iron - metabolism
Liver - blood supply
Liver - pathology
Liver Cirrhosis - complications
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Other diseases. Semiology
Portal Vein - pathology
Spleen - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinically, portal hypertension has been considered to be less common and less severe in patients with cirrhosis resulting from iron overload in homozygotes for genetic hemochromatosis than in patients with cirrhosis of other causes. To characterize the prevalence and progression of portal hypertension in genetic hemochromatosis (GH), 120 cirrhosis and iron‐overloaded patients were compared with a control group of 120 patients with postnecrotic cirrhosis (PNC) who were matched for gender, age, Child's class, and alcohol abuse. Gastroesophageal endoscopy and abdominal ultrasonography were performed at diagnosis and repeated every 12 months and every 6 months, respectively, to evaluate the presence and severity of varices, the caliber of the portal vein and its collaterals, and splenic size. At diagnosis a similar frequency of varices was observed in patients with GH (25%) and in PNC (24%), as well as of portal vein abnormalities and spleen enlargement. During the follow‐up period, all but two of the patients with GH were treated by phlebotomy and depleted of excess iron. After a mean of 6 ± 4.3 (SD) years of observations (range, 2 to 10 years), varices were improved or completely reversed in 26% of patients with cirrhosis and GH but in only 5% of those with PNC (P < .01). Bleeding from varices was observed in only one patient with GH but in five patients with PNC. Of 22 patients with GH in whom portal hypertension was unmodified or worsened, 16 had coexistent hepatic viral infection. The hazard risk for the development of de novo (i.e., a new occurrence) varices was 17 times higher in patients with PNC than in patients with GH (P < .001). The natural history of portal hypertension in patients with GH was substantially improved by phlebotomy therapy except in the presence of a coexistent hepatic viral infection. These results emphasize the need for intensive phlebotomy therapy even in patients diagnosed after the development of cirrhosis. (HEPATOLOGY 1995; 22:1127–1131.).
ISSN:0270-9139
1527-3350
DOI:10.1002/hep.1840220417